Research News for August 24, 2022
advertisement
- Beta Cell Reactivation May Be Viable Treatment for Patients With Type 1 Diabetes
- Serum α-KL, a potential early marker of diabetes complications in youth with T1D, is regulated by miRNA 192 (Full text HTML, PDF)
- Xenotransplantation and interspecies organogenesis: current status and issues (Full text HTML, PDF)
- Latent autoimmune diabetes in adults: a focus on β-cell protection and therapy (Full text HTML, PDF)
- Corresponding risk factors between cognitive impairment and type 1 diabetes mellitus: A narrative review (Full text HTML, PDF)
- Thymocyte regulatory variant alters transcription factor binding and protects from type 1 diabetes in infants
- Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
- Clinical Utility and Outcome Prediction of Early ZnT8-IgG Testing and Titer in Type 1 Diabetes
- Measurement of Serum N-Glycans in the Assessment of Early Vascular Aging (Arterial Stiffness) in Adults With Type 1 Diabetes
- Type 1 diabetes incidence increased during the COVID-19 pandemic years 2020-2021 in Czechia: results from a large population-based paediatric register
- Possible Relationship between the HLA-DRA1 Intron Haplotype of Three Single-Nucleotide Polymorphisms in Intron 1 of the HLA-DRA1 Gene and Autoantibodies in Children at Increased Genetic Risk for Autoimmune Type 1 Diabetes
- Co-transplantation of Islets-Laden Microgels and Biodegradable O 2-Generating Microspheres for Diabetes Treatment
- Circular RNAs in diabetes mellitus and its complications (Full text HTML, PDF)
- Type 1 diabetes with immune checkpoint inhibitors: A systematic analysis of clinical trials and a pharmacovigilance study of postmarketing data
- Transcriptome analysis of peripheral blood mononuclear cells in patients with type 1 diabetes mellitus
- Epidemiology of Type 1 Diabetes
